This web site is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.


Oxford BioTherapeutics

Drug Names(s): OX003

Description: OX003 is an antibody-drug conjugate (ADC) with an undisclosed mechanism of action. The ADC is based on a fully human Medarex antibody combined with a DNA toxin.

OX003 News

Additional information available to subscribers only:

  • Targets
  • Routes
  • Catalysts
  • Designations
  • Events

Request a Free Demo Subscriber Login Search for another drug